Johann Hermann

809 total citations
8 papers, 578 citations indexed

About

Johann Hermann is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Johann Hermann has authored 8 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Johann Hermann's work include Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Johann Hermann is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Johann Hermann collaborates with scholars based in Germany, United States and Switzerland. Johann Hermann's co-authors include F Zintl, Daniel Steinbach, Joachim Boos, Freimut H. Schilling, Bernhard Kremens, Martin Schrappe, Frank Berthold, Stefan Burdach, Thomas Klingebiel and Thorsten Simon and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Seminars in Thrombosis and Hemostasis.

In The Last Decade

Johann Hermann

8 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johann Hermann Germany	6	252	225	186	174	101	8	578
VM Santana United States	9	176 0.7×	185 0.8×	240 1.3×	310 1.8×	50 0.5×	11	674
Cristina Rosanda Italy	12	111 0.4×	194 0.9×	193 1.0×	59 0.3×	91 0.9×	38	479
Susan R. Wiersma United States	13	103 0.4×	137 0.6×	260 1.4×	78 0.4×	175 1.7×	16	517
Sebastian Vosberg Germany	10	51 0.2×	227 1.0×	288 1.5×	157 0.9×	154 1.5×	20	570
Pascale Halle France	11	101 0.4×	56 0.2×	257 1.4×	82 0.5×	49 0.5×	20	413
CR Kjeldsberg United States	11	94 0.4×	141 0.6×	66 0.4×	340 2.0×	66 0.7×	23	713
Caterina Fusco Italy	11	64 0.3×	114 0.5×	71 0.4×	161 0.9×	37 0.4×	22	616
LC Lasky United States	8	89 0.4×	59 0.3×	287 1.5×	153 0.9×	28 0.3×	12	413
Su Y. Kim United States	9	67 0.3×	119 0.5×	87 0.5×	88 0.5×	46 0.5×	11	391
A. Benger Canada	10	54 0.2×	114 0.5×	325 1.7×	161 0.9×	170 1.7×	18	546

Countries citing papers authored by Johann Hermann

Since Specialization

Citations

This map shows the geographic impact of Johann Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johann Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johann Hermann more than expected).

Fields of papers citing papers by Johann Hermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johann Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johann Hermann. The network helps show where Johann Hermann may publish in the future.

Co-authorship network of co-authors of Johann Hermann

This figure shows the co-authorship network connecting the top 25 collaborators of Johann Hermann. A scholar is included among the top collaborators of Johann Hermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johann Hermann. Johann Hermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Kentouche, Karim, et al.. (2006). von Willebrand Factor-Cleaving Protease (ADAMTS13) in the Course of Stem Cell Transplantation. Seminars in Thrombosis and Hemostasis. 32(2). 98–104. 19 indexed citations

2.

Creutzig, Ursula, Martin Zimmermann, Thomas Lehrnbecher, et al.. (2006). Less Toxicity by Optimizing Chemotherapy, but Not by Addition of Granulocyte Colony-Stimulating Factor in Children and Adolescents With Acute Myeloid Leukemia: Results of AML-BFM 98. Journal of Clinical Oncology. 24(27). 4499–4506. 137 indexed citations

3.

Berthold, Frank, Joachim Boos, Stefan Burdach, et al.. (2005). Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. The Lancet Oncology. 6(9). 649–658. 272 indexed citations

4.

Steinbach, Daniel, et al.. (2003). Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia.. PubMed. 9(3). 1083–6. 46 indexed citations

5.

Steinbach, Daniel, Johann Hermann, Susanne Viehmann, F Zintl, & Bernd Gruhn. (2002). Clinical implications of PRAME gene expression in childhood acute myeloid leukemia. Cancer Genetics and Cytogenetics. 133(2). 118–123. 93 indexed citations

6.

Steinbach, Daniel, Johann Hermann, Tim Littlewood, & F Zintl. (2001). Risk Group Definition in Children with Acute Myeloid Leukemia by Calculating Individual Risk Factors on the Basis of a Multivariate Stepwise Cox Regression Analysis. Leukemia & lymphoma. 42(6). 1289–1295. 2 indexed citations

7.

Steinbach, Daniel, Johann Hermann, Tim Littlewood, & F Zintl. (2001). Risk Group Definition in Children with Acute Myeloid Leukemia by Calculating Individual Risk Factors on the Basis of a Multivariate Stepwise Cox Regression Analysis. Leukemia & lymphoma. 42(6). 1289–1295. 1 indexed citations

8.

Hermann, Johann, et al.. (1998). Successful treatment of essential thrombocythemia with anagrelide in a child. Medical and Pediatric Oncology. 30(6). 367–370. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact